Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 175

1.

Estrogen with and without progestin: benefits and risks of short-term use.

LaCroix AZ.

Am J Med. 2005 Dec 19;118 Suppl 12B:79-87.

PMID:
16414331
2.
3.

Postmenopausal hormone therapy: cardiovascular risks.

[No authors listed]

Prescrire Int. 2003 Apr;12(64):65-9.

PMID:
12674130
4.

A comparative review of the risks and benefits of hormone replacement therapy regimens.

Warren MP.

Am J Obstet Gynecol. 2004 Apr;190(4):1141-67. Review.

PMID:
15118656
5.

Benefits and risks of postmenopausal hormone therapy when it is initiated soon after menopause.

Prentice RL, Manson JE, Langer RD, Anderson GL, Pettinger M, Jackson RD, Johnson KC, Kuller LH, Lane DS, Wactawski-Wende J, Brzyski R, Allison M, Ockene J, Sarto G, Rossouw JE.

Am J Epidemiol. 2009 Jul 1;170(1):12-23. doi: 10.1093/aje/kwp115. Epub 2009 May 25.

6.

New evidence regarding hormone replacement therapies is urgently required transdermal postmenopausal hormone therapy differs from oral hormone therapy in risks and benefits.

Modena MG, Sismondi P, Mueck AO, Kuttenn F, Lignières Bd, Verhaeghe J, Foidart JM, Caufriez A, Genazzani AR; TREAT.

Maturitas. 2005 Sep 16;52(1):1-10. Review.

7.

Menopause and stroke and the effects of hormonal therapy.

Lobo RA.

Climacteric. 2007 Oct;10 Suppl 2:27-31. Review.

PMID:
17882669
8.

Recent concerns surrounding HRT.

Armitage M, Nooney J, Evans S.

Clin Endocrinol (Oxf). 2003 Aug;59(2):145-55. Review.

PMID:
12864790
9.

Breast cancer risk with postmenopausal hormonal treatment.

Collins JA, Blake JM, Crosignani PG.

Hum Reprod Update. 2005 Nov-Dec;11(6):545-60. Epub 2005 Sep 8. Review. Erratum in: Hum Reprod Update. 2006 May-Jun;12(3):331.

PMID:
16150813
10.

Invited Commentary: Hormone therapy risks and benefits--The Women's Health Initiative findings and the postmenopausal estrogen timing hypothesis.

Banks E, Canfell K.

Am J Epidemiol. 2009 Jul 1;170(1):24-8. doi: 10.1093/aje/kwp113. Epub 2009 May 25.

PMID:
19468078
11.

Post-menopausal hormone replacement therapy (cont'd): risk-benefit balance in the hot seat.

[No authors listed]

Prescrire Int. 2004 Jun;13(71):106-9.

PMID:
15233153
12.

Hormone therapy: evolving concepts.

Hendrix SL.

Curr Opin Rheumatol. 2003 Jul;15(4):464-8. Review.

PMID:
12819476
14.

On the need to clarify and disseminate contemporary knowledge of hormone therapy initiated near menopause.

Langer RD.

Climacteric. 2010 Aug;13(4):303-6. doi: 10.3109/13697137.2010.496316.

PMID:
20540591
15.

Cardiovascular risk in women with non-specific chest pain (from the Women's Health Initiative Hormone Trials).

Robinson JG, Wallace R, Limacher M, Ren H, Cochrane B, Wassertheil-Smoller S, Ockene JK, Blanchette PL, Ko MG.

Am J Cardiol. 2008 Sep 15;102(6):693-9. doi: 10.1016/j.amjcard.2007.12.044. Epub 2008 Jul 2.

PMID:
18773990
16.

Postmenopausal hormones and coronary artery disease: potential benefits and risks.

Lobo RA.

Climacteric. 2007 Oct;10 Suppl 2:21-6. Review.

PMID:
17882668
17.
18.

KEEPS: The Kronos Early Estrogen Prevention Study.

Harman SM, Brinton EA, Cedars M, Lobo R, Manson JE, Merriam GR, Miller VM, Naftolin F, Santoro N.

Climacteric. 2005 Mar;8(1):3-12.

PMID:
15804727
19.

Effects of postmenopausal hormone therapy on incident atrial fibrillation: the Women's Health Initiative randomized controlled trials.

Perez MV, Wang PJ, Larson JC, Virnig BA, Cochrane B, Curb JD, Klein L, Manson JE, Martin LW, Robinson J, Wassertheil-Smoller S, Stefanick ML.

Circ Arrhythm Electrophysiol. 2012 Dec;5(6):1108-16. doi: 10.1161/CIRCEP.112.972224. Epub 2012 Nov 20.

20.

ACOG Committee Opinion No. 420, November 2008: hormone therapy and heart disease.

American College of Obstetricians and Gynecologists Committee on Gynecologic Practice.

Obstet Gynecol. 2008 Nov;112(5):1189-92. doi: 10.1097/AOG.0b013e31818e8782.

PMID:
18978127

Supplemental Content

Support Center